The phenomenon of treatment failures in Human African Trypanosomiasis

  title={The phenomenon of treatment failures in Human African Trypanosomiasis},
  author={R. Brun and R. Schumacher and C. Schmid and C. Kunz and C. Burri},
  journal={Tropical Medicine \& International Health},
Treatment of Human African Trypanosomiasis (HAT or sleeping sickness) relies on a few drugs which are old, toxic and expensive. The most important drug for the treatment of second stage infection is melarsoprol. During the last 50 years treatment failures with melarsoprol were not a major problem in Trypanosoma brucei gambiense patients. Commonly a relapse rate of 5–8% was reported, but in recent years it has increased dramatically in some important foci of T. b. gambiense sleeping sickness… Expand
Drug resistance in human African trypanosomiasis.
Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
  • P. Pyana, M. Séré, +7 authors V. Jamonneau
  • Biology, Medicine
  • Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
  • 2015
Recent developments in human African trypanosomiasis
Human African trypanosomiasis
Human African Trypanosomiasis


Drug resistance in pathogenic African trypanosomes: what hopes for the future?
Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.
Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.
Pharmacology of existing drugs for animal trypanosomiasis.
Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee.
  • J. Baker
  • Medicine
  • World Health Organization technical report series
  • 1998
Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol
  • Enoch Matovu, Monika Iten, +4 authors Ronald Kaminsky
  • Biology, Medicine
  • Tropical medicine & international health : TM & IH
  • 1997
Susceptibility of severe combined immuno‐deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesiense
Drug resistance in Sudanese Trypanosoma evansi.
Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
  • M. Iten, E. Matovu, R. Brun, R. Kaminsky
  • Biology, Medicine
  • Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit
  • 1995